相关实验视频
Updated: Jan 12, 2026

08:53
Localization, Identification, and Excision of Murine Adipose Depots
Published on: December 4, 2014
41.9K
一种双方向的纳米医药通过重塑脂肪位来抵消肥胖
Lingling Wang1, Jiahao Chen1, Jingwei Li1
1Department of Pharmacy, Institute of Metabolic Diseases and Pharmacotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.
概括
这项研究介绍了一种新的纳米平台,通过同时促进脂肪燃烧和减少炎症来对抗肥胖. 这种双重作用的方法有效地阻止了肥胖的进展,并改善了小鼠的代谢健康.
科学领域:
- 代谢性疾病研究研究.
- 纳米医学应用程序
- 免疫学和炎症的研究
背景情况:
- 肥胖症涉及减少发热和慢性炎症的有害循环.
- 促炎性巨细胞会损害脂肪细胞热生成,而功能障碍的脂肪细胞会使炎症恶化.
研究的目的:
- 开发一个双作用纳米平台来破坏肥胖反循环.
- 同时增强热生成和抑制脂肪组织中的炎症.
主要方法:
- 一个双端的纳米平台被设计用于有针对性的治疗.
- 过热被用来将白色脂肪组织转化为色脂肪,并减少炎症.
- 使用有针对性的STING通路阻塞来抑制炎症并创造一种免疫耐受性环境.
主要成果:
- 这种纳米药物在饮食诱导的肥胖小鼠的脂肪组织中优先积累.
- 系统能量消耗显著增加,脂肪组织炎症被重塑.
- 肥胖症的进展被停止,胰岛素敏感性得到改善,代谢并发症得到缓解.
结论:
- 纳米平台有效地打破了肥胖的病态循环,通过重新点燃热生成和减少炎症.
- 这一策略为代谢综合征提供了一个有前途的治疗方法.
- 同时准热生成和炎症为肥胖症提供了可行的治疗方法.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
230
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
230
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
163
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
163

